Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronac Mamtani

Showing results (11-20 of 198) with videos related to

Pageof 20
Sort By:
JAMA Oncology|October 28, 2021
Immunotherapy Adverse EffectsTimothy J Brown, Ronac Mamtani, Erin M Bange
Clinical Genitourinary Cancer|December 16, 2025
Real-World Enfortumab Vedotin ± Pembrolizumab Treatment-Based Toxicities and Associations With Survival in Advanced Urothelial CarcinomaMartin Kurian, Ronac Mamtani, Omar Elghawy, et al.
Journal of Cancer Policy|April 23, 2026
FDA-Authorized Oncology Artificial Intelligence and Machine Learning Devices and Their Clinical Evidence: A Cross-Sectional AnalysisHenry Litt, Paras Mehta, Aarush Sahni, et al.
Urologic Oncology|November 14, 2025
Outcomes of enfortumab vedotin plus pembrolizumab in patients with advanced urothelial cancer and severe renal dysfunctionHenry K Litt, Ronac Mamtani, Ryan D Chow
JCO Oncology Practice|September 17, 2020
Reply to J. Warner-Cohen et alErin M Bange, Kim A Reiss, Ronac Mamtani
Pharmacoepidemiology and Drug Safety|April 29, 2024
Comparing survival in trial- versus routine-care advanced urothelial cancer patients on immune checkpoint blockadeLucy S Wang, Rebecca A Hubbard, Ronac Mamtani
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 3, 2016
Pernicious anemia and colorectal cancer risk - A nested case-control studyBen Boursi, Ronac Mamtani, Kevin Haynes, et al.
Cancer Epidemiology|May 28, 2016
Parkinson's disease and colorectal cancer risk-A nested case control studyBen Boursi, Ronac Mamtani, Kevin Haynes, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2014
Digoxin use and the risk for colorectal cancerBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
European Journal of Gastroenterology & Hepatology|September 30, 2014
Height as an independent anthropomorphic risk factor for colorectal cancerBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
Pageof 20

Showing results (11-20 of 198) with videos related to

Sort By:
Pageof 20
JAMA Oncology|October 28, 2021
Immunotherapy Adverse EffectsTimothy J Brown, Ronac Mamtani, Erin M Bange
Clinical Genitourinary Cancer|December 16, 2025
Real-World Enfortumab Vedotin ± Pembrolizumab Treatment-Based Toxicities and Associations With Survival in Advanced Urothelial CarcinomaMartin Kurian, Ronac Mamtani, Omar Elghawy, et al.
Journal of Cancer Policy|April 23, 2026
FDA-Authorized Oncology Artificial Intelligence and Machine Learning Devices and Their Clinical Evidence: A Cross-Sectional AnalysisHenry Litt, Paras Mehta, Aarush Sahni, et al.
Urologic Oncology|November 14, 2025
Outcomes of enfortumab vedotin plus pembrolizumab in patients with advanced urothelial cancer and severe renal dysfunctionHenry K Litt, Ronac Mamtani, Ryan D Chow
JCO Oncology Practice|September 17, 2020
Reply to J. Warner-Cohen et alErin M Bange, Kim A Reiss, Ronac Mamtani
Pharmacoepidemiology and Drug Safety|April 29, 2024
Comparing survival in trial- versus routine-care advanced urothelial cancer patients on immune checkpoint blockadeLucy S Wang, Rebecca A Hubbard, Ronac Mamtani
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 3, 2016
Pernicious anemia and colorectal cancer risk - A nested case-control studyBen Boursi, Ronac Mamtani, Kevin Haynes, et al.
Cancer Epidemiology|May 28, 2016
Parkinson's disease and colorectal cancer risk-A nested case control studyBen Boursi, Ronac Mamtani, Kevin Haynes, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2014
Digoxin use and the risk for colorectal cancerBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
European Journal of Gastroenterology & Hepatology|September 30, 2014
Height as an independent anthropomorphic risk factor for colorectal cancerBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
Pageof 20